SCHEMBL1629700

SCHEMBL1629700

COc1ccc(-c2ccnn2-c2ccc(C#N)cc2)c(O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
NR3C2 P08235 1/20 0.43
POLB P06746 1/20 0.42
MAPKAPK2 P49137 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NOTUM Q6P988 1/20 0.39
ELANE P08246 1/20 0.39
CYP1A1 P04798 3/20 0.39
CYP1B1 Q16678 3/20 0.39
KDM5A P29375 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
CYP19A1 P11511 1/20 0.39
PTPN11 Q06124 1/20 0.38
NPC1 O15118 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
OPRK1 P41145 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629669 0.88 MAPT (0.60) MAPTNR3C2NPSR1NOTUMNPC1
SCHEMBL1628683 0.87 NPBWR1 (0.50) MAPTNR3C2NPSR1NOTUMNPC1
SCHEMBL1630056 0.86 POLB (0.46) MAPTPOLBELANECYP19A1ALDH1A1
SCHEMBL1629194 0.85 MAPT (0.53) MAPTNR3C2NPSR1NOTUMNPC1
SCHEMBL1630221 0.84 MAPT (0.58) MAPTNR3C2NPSR1NOTUMNPC1
SCHEMBL1628844 0.84 MAPT (0.52) MAPTNR3C2NPSR1NOTUMNPC1
SCHEMBL1629558 0.84 MAPT (0.52) MAPTNR3C2NPSR1NOTUMNPC1
SCHEMBL1630238 0.83 MAPT (0.51) MAPTNR3C2NPSR1NOTUMNPC1
SCHEMBL1631607 0.81 POLB (0.44) NR3C2POLBELANEKDM5AKDM5B
SCHEMBL1630086 0.81 NPSR1 (0.52) MAPTNPSR1NOTUMNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP claimed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P MAPT 2299/4885NR3C2 558/4885POLB 3527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.